Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1988-02-23 to 1988-03-25
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1988
Report date:
1988

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Version / remarks:
adopted 12 May 1981
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.6 (Skin Sensitisation)
Version / remarks:
25. April 1984
GLP compliance:
yes
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
The guinea pig test method described in OECD TG 406 provides suitable information for hazard identification.

Test material

Constituent 1
Chemical structure
Reference substance name:
Sodium ethylenesulphonate
EC Number:
221-242-5
EC Name:
Sodium ethylenesulphonate
Cas Number:
3039-83-6
Molecular formula:
C2H4O3S.Na
IUPAC Name:
sodium ethylenesulphonate
Constituent 2
Chemical structure
Reference substance name:
Water
EC Number:
231-791-2
EC Name:
Water
Cas Number:
7732-18-5
Molecular formula:
H2O
IUPAC Name:
oxidane
impurity 1
Chemical structure
Reference substance name:
Sodium 2-hydroxyethanesulphonate
EC Number:
216-343-6
EC Name:
Sodium 2-hydroxyethanesulphonate
Cas Number:
1562-00-1
Molecular formula:
C2H6O4S.Na
IUPAC Name:
sodium 2-hydroxyethanesulfonate
impurity 2
Chemical structure
Reference substance name:
Disodium 1,2-ethanedisulphonate
EC Number:
226-198-0
EC Name:
Disodium 1,2-ethanedisulphonate
Cas Number:
5325-43-9
Molecular formula:
C2H6O6S2.2Na
IUPAC Name:
disodium ethane-1,2-disulfonate
impurity 3
Chemical structure
Reference substance name:
2,2'-Oxybis-ethanesulfonic acid disodium salt
Cas Number:
63440-92-6
Molecular formula:
C4H8O7S2.2Na
IUPAC Name:
2,2'-Oxybis-ethanesulfonic acid disodium salt
impurity 4
Chemical structure
Reference substance name:
sodium 2-sulfonatoethyl sulfate
Molecular formula:
C2H4Na2O7S2
IUPAC Name:
sodium 2-sulfonatoethyl sulfate
impurity 5
Chemical structure
Reference substance name:
Sodium sulphate
EC Number:
231-820-9
EC Name:
Sodium sulphate
Cas Number:
7757-82-6
Molecular formula:
H2O4S.2Na
IUPAC Name:
disodium sulfate
impurity 6
Chemical structure
Reference substance name:
Sodium hydroxide
EC Number:
215-185-5
EC Name:
Sodium hydroxide
Cas Number:
1310-73-2
Molecular formula:
HNaO
IUPAC Name:
sodium hydroxide
Test material form:
liquid

In vivo test system

Test animals

Species:
guinea pig
Strain:
Pirbright-Hartley
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: HOECHST AG, Kastengrund, SPF-breed, Germany
- Weight at study initiation: 204 g - 286 g
- Housing: groups of five animals each
- Diet: ad libitum, ERKA feed Number 8300 for guinea pigs and rabbits
- Water: tap water, ad libitum
- Acclimation period: at least five days

ENVIRONMENTAL CONDITIONS
- Temperature: 22 +/- 3 °C
- Humidity: 50 +/- 20%
- Photoperiod: 12 hrs dark / 12 hrs light

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal
Vehicle:
physiological saline
Concentration / amount:
5%
Day(s)/duration:
Day 1 / 8 days
Adequacy of induction:
highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
Route:
epicutaneous, occlusive
Vehicle:
physiological saline
Concentration / amount:
10%
Day(s)/duration:
Day 9 / 2 days
Adequacy of induction:
other: selected concentration induced no mild-to-moderate irritation
Challenge
No.:
#1
Route:
epicutaneous, occlusive
Vehicle:
physiological saline
Concentration / amount:
10%
Day(s)/duration:
Day 22 / 1 day
No. of animals per dose:
Pretest:
6 animals for the determination of the non-irritating concentration
3 animals for the determination of the intradermal tolerance
Main test:
5 animals satellite group
5 animals control group
10 animals treated goup
Details on study design:
RANGE FINDING TESTS:

A. Determination of the non-irritating concentration
0.5 mL on the right and left flank, occlusive, exposure time: 24 h

- undiluted solution (30 % sodium ethylene sulphonate)
- 10% test solution in 0.9 % NaCl (3 % sodium ethylene sulphonate)
- 1% test item in 0.9 % NaCl (0.3 % sodium ethylene sulphonate)

At the end of the exposure period the skin of the animals was observed for erythema and oedema formation. Signs of skin irritation were scored according to the Draize scoring system.

B. Determination of the intradermal tolerance
Intradermal injection on the back of the animals (3 areas per animal, 2 injections per area)

1. area: 2x0.1 mL 5% test solution in 0.9 % NaCl (1.5 % sodium ethylene sulphonate)
2. area: 2x0.1 mL 1% test solution in 0.9 % NaCl (0.3 % sodium ethylene sulphonate)
3. area: 2x0.1 mL 0.2% test solution in 0.9 % NaCl (0.06 % sodium ethylene sulphonate)

MAIN STUDY

A. Intradermal induction (day 1)
Intradermal injection on the back of the animals (3 areas, 2 injections per area)

1. area: 2x0.1 mL 50% Freund´s Adjuvant
2. aerea: 2x0.1 mL 5% test solution in 0.9 % NaCl (1.5 % sodium ethylene sulphonate)
3. aerea: 2x0.1 mL 5% test item in Freund´s Adjuvant (1.5 % sodium ethylene sulphonate)

B. Epicutaneous induction (day 9)
0.5 mL on the intradermal injection area (back), occlusive, exposure time: 48 h

Treated group: 10% test solution in 0. 9% NaCl (3 % sodium ethylene sulphonate)
Control/satellite group: 0.9 % NaCl

C. CHALLENGE EXPOSURE (day 22, epicutaneous)
0.5 mL on the left flank, occlusive, exposure time: 24 h

Treated group and control group: 10% test solution in 0.9 % NaCl (3 % sodium ethylene sulphonate)
Positive control substance(s):
no

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
10% test solution in 0.9% NaCl (3% sodium ethylene sulphonate)
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
no clinical signs were observed
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
10% test item in 0.9% NaCl (3 % sodium ethylene sulphonate)
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
no clinical signs were observed
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
10% test item in 0.9% NaCl (3 % sodium ethylene sulphonate)
No. with + reactions:
0
Total no. in group:
5
Clinical observations:
no clinical signs were observed
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
10% test item in 0.9% NaCl (3 % sodium ethylene sulphonate)
No. with + reactions:
0
Total no. in group:
5
Clinical observations:
no clincal signs were observed
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
0%
No. with + reactions:
0
Total no. in group:
5
Clinical observations:
no clincal signs were observed
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
0%
No. with + reactions:
0
Total no. in group:
5
Clinical observations:
no clincal signs were observed
Group:
positive control
Remarks on result:
not measured/tested

Any other information on results incl. tables

Evaluation:


A response to challenge of at least 30% of the animals is considered as positive.


 


RANGE FINDING TESTS:


A. Determination of the non-irritating concentration


undiluted test solution (30% sodium ethylene sulphonate): Erythema and pustule formation, slight edema


10% test solution in 0.9% NaCl (3% sodium ethylene sulphonate): no skin irritation


1% test solution in 0.9% NaCl (0.3% sodium ethylene sulphonate): no skin irritation


 


B. Determination of the intradermal tolerance


5% test solution (1.5% sodium ethylene sulphonate): slight redness and edema on the injection site.


1% test solution (0.3% sodium ethylene sulphonate): no skin irritation


0.2% test solution (0.06% sodium ethylene sulphonate): no skin irritation


MAIN STUDY


A. Intradermal induction


50% Freund´s Adjuvant: Redness and edema on the injection site which turned into indurations


5% test solution in Freund´s Adjuvant (1.5% sodium ethylene sulphonate): Redness and edema on the injection site which turned into indurations


B. Epicutaneous induction


The control and satellite group showed injection sites with open wound, scabbing and necrosis when the occlusive gauze was removed (day 11).


C. CHALLENGE EXPOSURE


24 h and 48 h after the occlusive gauze was removed the animals of the treated and the control group revealed no signs of skin irritation.


Body weight and clinical signs:


No clinical signs were observed during the study period. The body weight gains of the treated animals were mostly normal. Two animals if the control group showed only a slight increase in body weight development.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
Under the condition of this study a test solution containing 30% sodium ethylene sulphonate did not induce skin sensitisation. Even if the concentrations at epicutaneous induction were too low according to the guideline requirements (i.e. the selected concentration induced no mild-to-moderate irritation), in combination with intradermal application irritation was observed and therefore, the study is acceptable and revealed that the substance has no sensitisation potential.
Executive summary:

In a guinea pig maximisation test according to OECD 406 and GLP guideline (Hoechst AG (a), 1988) a test solution containing 30% sodium ethylene sulphonate was used. For the determination of the non-irritating concentration and of the intradermal tolerance a range finding test was conducted. Thereby, 0.5 mL undiluted test solution (30% sodium ethylene sulphonate) induced erythema, slight oedema and pustles whereas 10% test solution (3% sodium ethylene sulphonate) induced no skin irritations after epicutaneous occlusive exposure (24 hours) on the right and left flank of 6 animals. In the main study ten female Pribright-Hartley guinea pigs were treated on day 1 by two intradermal injections on the back in three areas with 50% Freund´s Adjuvant (1. area, 2 x 0.1 mL), 5% test solution in 0.9% NaCl (2. area 2 x 0.1 mL, 1.5 % sodium ethylene sulphonate) and 5% test solution in Freund´s Adjuvant (3. area, 2 x 0.1 mL, 1.5% sodium ethylene sulphonate). On day 9, ten animals received 0.5 mL of the test solution by dermal application on the intradermal injection area (back), occlusive, for an exposure time of 48 hours. Thereby, animals were treated with 10% test solution in 0.9% NaCl (3% sodium ethylene sulphonate). Five control animals and five animals of a satellite group were treated with a 0.9% NaCl solution. On challenge exposure (day 22) animals (ten for the treated group and five for the control group) were treated with 0.5 mL of the test solution on the left flank by an occlusive dressing for an exposure time of 24 hours. All animals received 10% test solution in 0.9% NaCl (3% sodium ethylene sulphonate). 24 h and 48 h after the occlusive gauze was removed the animals of the treated and the control group revealed no signs of skin irritation.No clinical signs were observed during the study period. The body weight gains of the treated animals were mostly normal. Two animals of the control group showed only a slight increase in body weight development. After intradermal induction in animals treated with 50% Freund´s Adjuvant and with 5% test solution in Freund´s Adjuvant redness and oedema on the injection site were observed which turned into indurations. After the dermal induction, the control and satellite group showed injection sites with open wound, scabbing and necrosis when the occlusive gauze was removed (day 11). In conclusion, even if the concentrations at epicutaneous induction were too low according to the guideline requirements (i.e. the selected concentration induced no mild-to-moderate irritation), in combination with intradermal application skin irritation was observed and therefore, the study is acceptable and revealed that the substance has no sensitisation potential. Furthermore, the numberof 10 animals chosen is considered sufficient since a clear negative result has been observed.